Phys.org

Temporary liver coating may improve safety and targeting of mRNA vaccines and cancer therapies

Temporary liver coating may improve safety and targeting of mRNA vaccines and cancer therapiesWorldPing

With the commercialization of mRNA vaccines against COVID-19, research and development into the application of mRNA in vaccines and pharmaceuticals is accelerating.

This is a short WorldPing brief. The full report was published by Phys.org.

Read the full report at Phys.org

Related news

Will personalised mRNA vaccines transform cancer treatments?WorldPing
New Scientist

Will personalised mRNA vaccines transform cancer treatments?

A personalised mRNA cancer vaccine has produced positive results in a final-stage trial involving skin cancer, raising hopes that this approach could work against many cancers…

Brief by WorldPing · Original reporting by New Scientist

Designing supramolecular therapies to cross the blood-brain barrierWorldPing
Phys.org

Designing supramolecular therapies to cross the blood-brain barrier

A new Northwestern Medicine study has uncovered key molecular design principles that could help supramolecular therapeutics cross the blood-brain barrier, a major challenge for this novel approach to treating neurological disorders.

Brief by WorldPing · Original reporting by Phys.org